Market Research Logo

Europe Narcolepsy Market and Competitive Landscape – 2017

Europe Narcolepsy Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Narcolepsy Market and Competitive Landscape – 2017, provides comprehensive insights into Narcolepsy pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Narcolepsy market size and drug sales. This research also provides insights into Narcolepsy epidemiology and late stage pipeline.
The report is classified into nine sections – Narcolepsy overview with definitions, symptoms, etiology, diagnosis, treatment options; Narcolepsy pipeline insights covering late stage clinical trials pipeline; Narcolepsy prevalence trends by countries; Narcolepsy market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Narcolepsy pipeline: Find out the drugs in clinical trials for Narcolepsy by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Narcolepsy epidemiology: Find out the prevalence of Narcolepsy by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Narcolepsy products: Identify key products marketed and prescribed for Narcolepsy by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Narcolepsy market size: Find out the market size for Narcolepsy drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Narcolepsy drug sales: Find out the sales of Narcolepsy drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Narcolepsy drugs sales forecast: Sales forecast for Narcolepsy drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Narcolepsy market share analysis: Find out the market shares of Narcolepsy drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Narcolepsy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Narcolepsy market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Narcolepsy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Narcolepsy: Disease Overview
1.1. Narcolepsy Symptoms
1.2. Narcolepsy Etiology
1.3. Narcolepsy Diagnosis
1.4. Narcolepsy Treatment Options
2. Narcolepsy Pipeline Insights
2.1. Narcolepsy Phase 3 Clinical Trials
2.2. Narcolepsy Phase 2 Clinical Trials
2.3. Narcolepsy Phase 1 Clinical Trials
3. Narcolepsy Epidemiology Analysis
4. Germany Narcolepsy Market Insights
4.1. Marketed Products for Narcolepsy in Germany
4.2. Germany Narcolepsy Market Size & Forecast
4.3. Germany Narcolepsy Product Sales Forecast
4.4. Germany Narcolepsy Market Share Analysis
5. France Narcolepsy Market Insights
5.1. Marketed Products for Narcolepsy in France
5.2. France Narcolepsy Market Size & Forecast
5.3. France Narcolepsy Product Sales Forecast
5.4. France Narcolepsy Market Share Analysis
6. Italy Narcolepsy Market Insights
6.1. Marketed Products for Narcolepsy in Italy
6.2. Italy Narcolepsy Market Size & Forecast
6.3. Italy Narcolepsy Product Sales Forecast
6.4. Italy Narcolepsy Market Share Analysis
7. Spain Narcolepsy Market Insights
7.1. Marketed Products for Narcolepsy in Spain
7.2. Spain Narcolepsy Market Size & Forecast
7.3. Spain Narcolepsy Product Sales Forecast
7.4. Spain Narcolepsy Market Share Analysis
8. UK Narcolepsy Market Insights
8.1. Marketed Products for Narcolepsy in UK
8.2. UK Narcolepsy Market Size & Forecast
8.3. UK Narcolepsy Product Sales Forecast
8.4. UK Narcolepsy Market Share Analysis
9. Europe Narcolepsy Market Insights
9.1. Europe Narcolepsy Market Size & Forecast
9.2. Europe Narcolepsy Product Sales Forecast
9.3. Europe Narcolepsy Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Narcolepsy Phase 3 Clinical Trials, Global, 2017
Table 2: Narcolepsy Phase 2 Clinical Trials, Global, 2017
Table 3: Narcolepsy Phase 1 Clinical Trials, Global, 2017
Table 4: Narcolepsy Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Narcolepsy in Germany, 2017
Table 6: Germany Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Narcolepsy Product Sales ($mn), 2012 - 2021
Table 8: Germany Narcolepsy Market Trends, 2012 - 2021
Table 9: Marketed Products for Narcolepsy in France, 2017
Table 10: France Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Narcolepsy Product Sales ($mn), 2012 - 2021
Table 12: France Narcolepsy Market Trends, 2012 - 2021
Table 13: Marketed Products for Narcolepsy in Italy, 2017
Table 14: Italy Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Narcolepsy Product Sales ($mn), 2012 - 2021
Table 16: Italy Narcolepsy Market Trends, 2012 - 2021
Table 17: Marketed Products for Narcolepsy in Spain, 2017
Table 18: Spain Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Narcolepsy Product Sales ($mn), 2012 - 2021
Table 20: Spain Narcolepsy Market Trends, 2012 - 2021
Table 21: Marketed Products for Narcolepsy in UK, 2017
Table 22: UK Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Narcolepsy Product Sales ($mn), 2012 - 2021
Table 24: UK Narcolepsy Market Trends, 2012 - 2021
Table 25: Europe Narcolepsy Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Narcolepsy Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Narcolepsy Pipeline by Phase (%), Global, 2017
Figure 2: Narcolepsy Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Narcolepsy Market Size ($mn), 2012 - 2021
Figure 4: Germany Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 5: Germany Narcolepsy Market Share by Products (%), 2016
Figure 6: Germany Narcolepsy Market - Future Market Share (%), 2021
Figure 7: France Narcolepsy Market Size ($mn), 2012 - 2021
Figure 8: France Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 9: France Narcolepsy Market Share by Products (%), 2016
Figure 10: France Narcolepsy Market - Future Market Share (%), 2021
Figure 11: Italy Narcolepsy Market Size ($mn), 2012 - 2021
Figure 12: Italy Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 13: Italy Narcolepsy Market Share by Products (%), 2016
Figure 14: Italy Narcolepsy Market - Future Market Share (%), 2021
Figure 15: Spain Narcolepsy Market Size ($mn), 2012 - 2021
Figure 16: Spain Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 17: Spain Narcolepsy Market Share by Products (%), 2016
Figure 18: Spain Narcolepsy Market - Future Market Share (%), 2021
Figure 19: UK Narcolepsy Market Size ($mn), 2012 - 2021
Figure 20: UK Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 21: UK Narcolepsy Market Share by Products (%), 2016
Figure 22: UK Narcolepsy Market - Future Market Share (%), 2021
Figure 23: Europe Narcolepsy Market Size ($mn), 2012 - 2021
Figure 24: Europe Narcolepsy Product Sales ($mn), 2012 - 2021
Figure 25: Europe Narcolepsy Market Share by Products (%), 2016
Figure 26: Europe Narcolepsy Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report